EXHIBIT 32.2
Published on November 15, 2004
EXHIBIT 32.2
CERTIFICATION PURSUANT TO RULE 13a-14(b) OR RULE 15d-14(b) OF THE
SECURITIES EXCHANGE ACT OF 1934 AND U.S.C. SECTION 1350
I, Alan Fuhrman, Senior Vice President and Chief Financial Officer of Sonus
Pharmaceuticals, Inc. (the "Company"), certify, pursuant to Rule 13a-14(b) or
Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section
1350, that:
(1) the Quarterly Report on Form 10-Q of the Company for the quarterly period
ended September 30, 2004 (the "Report") fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934 (15 U.S.C. 78m or 780(d)); and
(2) the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
Dated: November 15, 2004
/s/ Alan Fuhrman
-------------------------------------------
Alan Fuhrman
Senior Vice President and Chief Financial
Officer